Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury

Critical Care Medicine

Volumn 36, Issue 3, 2008, Pages 975-978

  Adembri, Chiara ^a   Massagrande, Alessandra ^a   Tani, Alessia ^b   Miranda, Marco ^a   Margheri, Martina ^b   De Gaudio, Raffaele ^a   Pellegrini Giampietro, Domenico E ^c  

^a Department of Critical Care Medicine   (Australia)

^b and Forensic Medicine ^*  (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Carbamylated erythropoietin; Erythropoietin; Neuroprotection; Organotypic hippocampal slices; Propidium iodide; Traumatic brain injury

Indexed keywords

CARBAMYLATED RECOMBINANT ERYTHROPOIETIN; NEUROPROTECTIVE AGENT; PROPIDIUM IODIDE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; CARBAMYLATED ERYTHROPOIETIN; DRUG DERIVATIVE; ERYTHROPOIETIN;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL DEATH; CONTROLLED STUDY; CULTURE MEDIUM; EXPERIMENTAL MODEL; FLUORESCENCE ANALYSIS; HIPPOCAMPUS; IN VITRO STUDY; MECHANICAL STRESS; MICROSCOPY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURY; WISTAR RAT;

ANIMALS; BRAIN INJURIES; ERYTHROPOIETIN; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 44449138540     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0B013E3181644343     Document Type: Article

References (10)

1. Buemi M, Cavallaro E, Floccari F, et al: Erythropoietin and the brain: From neurodevelopment to neuroprotection. Clin Sci (Lond) 2002;103:275-282
2. Ehrenreich H, Hasselblatt M, Dembowski C, et al: Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002;8:495-505
3. Leist M, Ghezzi P, Grasso G, et al: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004;305:239-242
4. Montero M, Poulsen FR, Noraberg J, et al: Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures. Exp Neurol 2007;204:106-117
5. Villa P, van Beek J, Larsen AK, et al: Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab 2007;27:552-563
6. Wang Y, Zhang ZG, Rhodes K, et al: Postischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol 2007;151:1377-1384
7. Mahmood A, Lu D, Qu C, et al: Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin. J Neurosurg 2007;107:392-397 (Pubitemid 47219384)
8. Adembri C, Bechi A, Meli E, et al: Erythropoietin attenuates post-traumatic injury in organotypic hippocampal slices. J Neurotrauma 2004;21:1103-1112
9. Sundstrom L, Morrison B III, Bradley M, et al: Organotypic cultures as tools for functional screening in the CNS. Drug Discov Today 2005;10:993-1000
10. Brines M, Grasso G, Fiordaliso F, et al: Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA 2004;101:14907-14912